Carmen Garrido (Gaetan Jego, Gaëtan Jego)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Inflammatory Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Cabaud Gibouin, Manon Durand, Christophe Boudesco, François Hermetet, Kristyna Nozickova, Catherine Chassagne-Clement, Mayssa Abdelwahed, Pavel Klener, Carmen Garrido, Carmen Garrido
First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma. Leukemia 38 (8) (2024)
Vincent Cabaud Gibouin, Manon Durand, Christophe Boudesco, François Hermetet, Kristyna Nozickova, Catherine Chassagne-Clement, Mayssa Abdelwahed, Pavel Klener, Carmen Garrido, Carmen Garrido
First-in-class inhibitor of HSP110 blocks BCR activation through SYK phosphorylation in diffuse large B-cell lymphoma. Leukemia (2024)
Vincent Cabaud Gibouin, Manon Durand, Ronan Quéré, François Girodon, Carmen Garrido, Carmen Garrido
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches. Cancers 15 (3) (2023)
Vincent Cabaud Gibouin, Manon Durand, Ronan Quéré, François Girodon, Carmen Garrido, Carmen Garrido
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches. Cancers 15 (3) (2023)
Hadjer Miloudi, Élodie Bohers, François Guillonneau, Antoine Taly, Vincent Cabaud Gibouin, Pierre-Julien Viailly, Carmen Garrido, Luca Grumolato, Fabrice Jardin, Brigitte Sola
XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma. Cancers 12 (10) (2020)
Steven De Almeida, Mathilde Regimbeau, Carmen Garrido, Carmen Garrido, François Girodon, François Hermetet
Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms. Cancers 12 (9) (2020)
Gaëtan Jego, François Hermetet, François Girodon, Carmen Garrido
Chaperoning STAT3/5 by Heat Shock Proteins: Interest of Their Targeting in Cancer Therapy. Cancers 12 (1) (2019)
Christophe Boudesco, Els Verhoeyen, Laurent Martin, Catherine Chassagne-Clement, Leila Salmi, Rana Mhaidly, Céline Pangault, Thierry Fest, Selim Ramla, Fabrice Jardin, Olaf-Oliver Wolz, Alexander N R Weber, Carmen Garrido, Carmen Garrido
HSP110 sustains chronic NF-κB signaling in activated B-cell diffuse large B-cell lymphoma through MyD88 stabilization. Blood 132 (5) (2018)